SCA Prep

Endocrine and Diabetes

Diabetes management, thyroid disorders, adrenal conditions and metabolic syndromes.

Last reviewed

Use this quick reference guide to study and ensure you have mastered these common cases from the curriculum. You can generate specific cases on our SCA cases page or even practice them with our specialised and UK guidelines trained AI Actors.

1Type 2 Diabetes: Diagnosis and First-line Management

Type 2 diabetes is a progressive metabolic disorder associated with insulin resistance.

Diagnosis

  • Symptomatic: Fasting plasma glucose โ‰ฅ7.0 mmol/L OR Random plasma glucose โ‰ฅ11.1 mmol/L OR HbA1c โ‰ฅ48 mmol/mol (6.5%).
  • Asymptomatic: Two abnormal test results are required to confirm diagnosis (e.g., two HbA1c results โ‰ฅ48 mmol/mol).
  • Pre-diabetes: HbA1c 42โ€“47 mmol/mol (6.0โ€“6.4%). Offer annual review and intensive lifestyle advice.

Initial Management

  • Lifestyle: Diet, exercise, and weight loss (aim for 5-10% body weight loss) are the foundation. Structured education (e.g., DESMOND) should be offered.
  • First-line Medication: Metformin (standard release) 500mg daily, titrated up to 2g daily. Use modified-release (MR) if GI side effects occur.
  • HbA1c Target: Usually 48 mmol/mol (6.5%) for new diagnosis managed with lifestyle or Metformin alone. Relax target (e.g., 53 mmol/mol) for those on drugs associated with hypoglycaemia (sulfonylureas/insulin) or in frailty.

2Type 2 Diabetes: Escalation and Complications

If HbA1c rises above 58 mmol/mol (7.5%) on Metformin, or if individual targets are not met:

Visual explanation

SGLT2 inhibitors: recognise euglycaemic DKA

Taking an SGLT2 inhibitor + symptoms suggesting DKA

Nausea or vomiting, abdominal pain, deep rapid breathing or unusual drowsiness.

Glucose

Near-normal

Glucose

Raised

Both need the same urgent response

  • Stop the SGLT2 inhibitor if DKA is suspected.
  • Check ketones; blood testing is preferred.
  • Arrange emergency hospital assessment for suspected DKA. Do not delay transfer to obtain a ketone result.

Remember: Near-normal glucose does not exclude DKA. Ask about recent illness, reduced intake, dehydration, surgery or insulin reduction. After DKA, do not restart the SGLT2 inhibitor unless another cause has been identified and resolved, with specialist review.

Simplified teaching diagram. Sources: MHRA: SGLT2 inhibitors and DKA ยท MHRA: blood ketone monitoring

Escalation (Dual Therapy)

  • Cardiovascular Disease (CVD) or Heart Failure: Add an SGLT2 inhibitor (e.g., Dapagliflozin, Empagliflozin) with proven cardiovascular benefit immediately, regardless of HbA1c.
  • No CVD: Options include Gliptins (DPP-4 inhibitors), Pioglitazone, Sulfonylureas, or SGLT2 inhibitors. Choice depends on weight, frailty, and side effect profile.
  • Triple Therapy: Usually involves Metformin + two other oral agents, or starting insulin/GLP-1 agonist.

Complications Screening (Annual Review)

  • Eyes: Retinopathy screening (photographs).
  • Feet: Neuropathy/vascular check.
  • Kidneys: ACR (Albumin:Creatinine Ratio) and eGFR. ACR >3mg/mmol indicates microalbuminuria โ€“ start ACE-inhibitor/ARB even if normotensive.

3Type 1 Diabetes: Diagnosis and Emergency

Autoimmune destruction of pancreatic beta cells leading to absolute insulin deficiency.

Diagnosis (The 4 Ts)

Toilet (polyuria)
Thirsty (polydipsia)
Tired
Thinner (weight loss)
  • Ketones: Always check blood or urine ketones in any patient suspected of new diabetes.
  • Antibodies: GAD antibodies confirm diagnosis but do not wait for results to start insulin.

Emergency: Diabetic Ketoacidosis (DKA)

Medical emergency. Symptoms: Vomiting, abdominal pain, Kussmaul breathing (deep/laboured), pear-drop breath.

Action: Immediate hospital admission. Do not delay.

Primary Care Role

  • Sick Day Rules: Never stop insulin. Increase frequency of monitoring. Increase dose if needed. Check ketones.
  • Technology: Familiarise with Flash Glucose Monitoring (Libre sensors) which are now standard for many patients.

4Hypothyroidism and Subclinical Hypothyroidism

Underactive thyroid, usually autoimmune (Hashimoto's thyroiditis).

Visual explanation

Thyroid function tests: patterns and pitfalls

Common patterns in untreated, non-pregnant adults. Use local reference ranges.

TSH โ†‘

Add FT4

FT4 โ†“
โ†ณ Overt primary hypothyroidism
FT4 in range
โ†ณ Subclinical hypothyroid pattern

TSH โ†“

Add FT4 + FT3

FT4 and/or FT3 โ†‘
โ†ณ Thyrotoxicosis; establish the cause
Both in range
โ†ณ Subclinical hyperthyroid pattern
The pituitary exception: low FT4 with low or inappropriately normal TSH can indicate central hypothyroidism. Seek specialist advice; also consider illness, medicines and assay interference.

Remember: A biochemical pattern is a starting point, not an automatic treatment decision. Check symptoms, medicines (including biotin), acute illness and persistence. Measure TSH and FT4 together if pituitary disease is suspected.

Simplified teaching diagram. Sources: NICE NG145: thyroid testing ยท ETA: central hypothyroidism

Diagnosis

High TSH and Low Free T4.

Subclinical Hypothyroidism

High TSH but Normal Free T4. Repeat in 3 months. Treat if TSH >10, or if TSH 4-10 and symptomatic, goitre, or raised TPO antibodies. Always treat in pregnancy/planning pregnancy.

Management

  • Levothyroxine: Start 50-100mcg daily (lower dose 25mcg in elderly/ischaemic heart disease).
  • Target: Aim to normalise TSH (usually 0.5โ€“2.5 mU/L). Check TSH every 3 months until stable, then annually.
  • Administration: Take on an empty stomach, 30 mins before breakfast/caffeine.

5Hyperthyroidism and Thyrotoxicosis

Overactive thyroid. Most common cause is Graves' disease.

Clinical Features

Weight loss despite increased appetite, heat intolerance, palpitations, tremor, anxiety, diarrhoea. Eye signs (exophthalmos) specific to Graves'.

Investigations

TSH (suppressed <0.05), Free T4/T3 (raised). TSH Receptor Antibodies (positive in Graves').

Management

  • Beta-blockers: Propranolol for rapid symptom control (tremor/palpitations).
  • Referral: Endocrinology for Carbimazole (titration or block-and-replace) or Radioiodine.

Red Flag

Sore throat/fever on Carbimazole โ€“ urgent FBC to check for agranulocytosis (neutropenia).

6Obesity and Weight Management

Obesity is a chronic relapsing condition. Calculate BMI and measure waist circumference.

Assessment

Check for comorbidities (Type 2 Diabetes, Hypertension, Sleep Apnoea, NAFLD, Osteoarthritis).

Management Tiers

  • Lifestyle: Diet and physical activity.
  • Pharmacological: Orlistat (lipase inhibitor) if BMI โ‰ฅ30 (or โ‰ฅ28 with risk factors). Criteria: 5% weight loss at 3 months to continue. Newer GLP-1 agonists (e.g., Semaglutide/Wegovy) are available via specialist weight management services (Tier 3/4).
  • Surgical: Bariatric surgery referral (Tier 4) if BMI โ‰ฅ40 (or 35 with comorbidities) and all other measures failed.

7Polycystic Ovary Syndrome (PCOS)

Common endocrine disorder affecting reproductive age women.

Rotterdam Criteria (2 out of 3 required)

  • โ€ข Oligo/Anovulation (irregular/infrequent periods).
  • โ€ข Clinical or biochemical hyperandrogenism (hirsutism, acne, raised testosterone).
  • โ€ข Polycystic ovaries on ultrasound.

Management

  • Metabolic: Screen for Diabetes (HbA1c) and CVD risk. Weight loss is first-line for all symptoms.
  • Menstrual Regulation: Combined Oral Contraceptive Pill (COCP) or cyclical progestogens (to prevent endometrial hyperplasia).
  • Hirsutism: COCP, topical Eflornithine, or laser treatment.
  • Fertility: Referral if not conceiving. Clomifene or Letrozole (specialist use).

8Vitamin D Deficiency

Very common in the UK, especially in winter.

Testing

Only test if symptomatic (bone pain, muscle weakness, fatigue) or high risk (darker skin, housebound, covered). Do not screen asymptomatics.

Management

  • Deficiency (<25 nmol/L): High-dose loading (e.g., 40,000 IU weekly for 7 weeks) followed by maintenance.
  • Insufficiency (25-50 nmol/L): Maintenance dose (800-2000 IU daily). Often advised to buy over-the-counter (OTC).
  • Severe: If calcium is abnormal or symptoms severe, consider specialist advice/investigation for osteomalacia.

9Adrenal Insufficiency (Addison's Disease)

Rare but life-threatening deficiency of cortisol and aldosterone.

Clinical Features

Fatigue, weight loss, hyperpigmentation (palmar creases, buccal mucosa), hypotension (postural drop), salt craving.

Investigations

  • Electrolytes: Low Sodium (Hyponatraemia), High Potassium (Hyperkalaemia).
  • Cortisol: 9am Cortisol. If low (<100 nmol/L), highly suggestive. If >400-500, unlikely.
  • Definitive Test: Short Synacthen Test (Specialist).

Emergency (Addisonian Crisis)

Collapse, shock, severe vomiting.

Action: IM Hydrocortisone immediately. Do not wait for bloods. Admission.

Sick Day Rules

Patients must double steroid dose during fever/illness and carry an emergency injection kit/steroid card.

10Hyperlipidaemia and Cardiovascular Risk

Primary prevention of CVD.

Assessment

QRISK3 score to estimate 10-year risk of heart attack/stroke.

Primary Prevention

  • โ€ข Offer Statin (Atorvastatin 20mg) if QRISK โ‰ฅ10%.
  • โ€ข Lifestyle modification is always first-line or concurrent.
  • โ€ข Check LFTs before starting and at 3 months and 12 months.

Secondary Prevention (Established CVD)

  • โ€ข Atorvastatin 80mg is standard.
  • โ€ข Target: Non-HDL cholesterol reduction >40% from baseline.

Familial Hypercholesterolaemia (FH)

Suspect if Total Cholesterol >7.5 mmol/L (or LDL >4.9) plus family history of premature heart disease. Do not use QRISK (it underestimates risk). Refer for specialist assessment/genetic testing.